Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Shanghai Medical College of Fudan University · Fudan University Shanghai Cancer Center · +1 more institution
Abstract
In recent years, cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has achieved considerable success in the clinic. However, ICIs are significantly limited by the fact that only one third of patients with most types of cancer respond to these agents. The induction of cell death mechanisms other than apoptosis has gradually emerged as a new cancer treatment strategy because most tumors harbor innate resistance to apoptosis. However, to date, the possibility of combining these two modalities has not been discussed systematically. Recently, a few studies revealed crosstalk between distinct cell death mechanisms and antitumor immunity. The induction of pyroptosis, ferroptosis, and necroptosis…
Citation impact
- FWCI
- 115.95
- Percentile
- 100%
- References
- 171
Authors
9- RTRong TangCorresponding
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
- JXJin Xu
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
- BZBo Zhang
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
- JLJiang Liu
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
- CLChen Liang
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
Topics & keywords
- Pyroptosis
- Necroptosis
- Programmed cell death
- Immunogenic cell death
- Granzyme
- Oncolytic virus
- Cancer research
- Immunotherapy
- Good health and well-being
Funding
- NSNational Science FoundationAward: 81625016
- IRInnovative Research Group Project of the National Natural Science Foundation of ChinaAward: No. 81802352
- SAShanghai Anti-Cancer Association
- NNNational Natural Science Foundation of ChinaAwards: 81772555, 81802352, SHDC12018109, SHDC12019109, 2019-01-07-00-07-E00057, 81625016, 81902428, 20QA1402100, 2019-01
- SHShanghai Hospital Development CenterAwards: SHDC12018109, SHDC12019109, 81802352, 20QA1402100, 2019-01-07-00-07-E00057
- SRShanghai Rising-Star ProgramAwards: SHDC12018109, 20QA1402100, 81802352, 2019-01-07-00-07-E00057, SHDC12019109
- CNChina National Funds for Distinguished Young ScientistsAward: No. 81625016
- EAEducation and Scientific Research Project of ShanghaiAward: 2019-01-07-00-07-E00057
- NSNational Science Fund for Distinguished Young ScholarsAward: 81625016